BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1677910)

  • 1. Density gradient separation of hematopoietic stem cells in autologous bone marrow transplantation.
    Iacone A; Quaglietta AM; D'Antonio D; Accorsi P; Dragani A; Angrilli F; Berardi A; Angelini A; Di Bartolomeo P; Di Bartolomeo G
    Haematologica; 1991 Mar; 76 Suppl 1():18-21. PubMed ID: 1677910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Density-gradient separation for 4-hydroperoxycyclophosphamide purging of autologous bone marrow grafts.
    Rowley S; Davis J; Braine H; Jones R; Yeager A; Saral R; Santos G
    Prog Clin Biol Res; 1990; 333():369-77. PubMed ID: 2308991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantation.
    Ferrero D; Tarella C; Cherasco C; Bondesan P; Omedè P; Ravaglia R; Caracciolo D; Castellino C; Pileri A
    Bone Marrow Transplant; 1998 Feb; 21(4):409-13. PubMed ID: 9509977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Density-gradient separation of autologous bone marrow grafts before ex vivo purging with 4-hydroperoxycyclophosphamide.
    Rowley SD; Davis JM; Piantadosi S; Jones RJ; Yeager AM; Santos GW
    Bone Marrow Transplant; 1990 Nov; 6(5):321-7. PubMed ID: 2291993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration of bone marrow progenitor cells by separation on a Percoll gradient using the Haemonetics model 30.
    Humblet Y; Lefebvre P; Jacques JL; Bosly A; Feyens AM; Sekhavat M; Agaliotis D; Symann M
    Bone Marrow Transplant; 1988 Jan; 3(1):63-7. PubMed ID: 2901880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and automated processing of bone marrow grafts without Ficoll density gradient for transplantation of cryopreserved autologous or ABO-incompatible allogeneic bone marrow.
    Schanz U; Gmür J
    Bone Marrow Transplant; 1992 Dec; 10(6):507-13. PubMed ID: 1490200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J; Fehér I
    Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma interacts with mafosfamide toxicity to normal haematopoietic progenitor cells: impact on in vitro marrow purging.
    Giarratana MC; Gorin NC; Douay L
    Nouv Rev Fr Hematol (1978); 1995; 37(2):125-30. PubMed ID: 7644349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (ASTA Z 7557).
    Douay L; Mary JY; Giarratana MC; Najman A; Gorin NC
    Exp Hematol; 1989 Jun; 17(5):429-32. PubMed ID: 2653856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging.
    Beran M; Andersson BS; Wang Y; McCredie KB; Farquhar D
    Cancer Res; 1988 Jan; 48(2):339-45. PubMed ID: 3275495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effects of GM-CSF and IL-3 on hematopoietic cell recovery in bone marrow and blood after autologous transplantation with mafosfamide-purged marrow in lymphoid malignancies.
    Albin N; Douay L; Fouillard L; Laporte JP; Isnard F; Lesage S; Ozsahin H; Bardinet D; Najman A; Gorin NC
    Bone Marrow Transplant; 1994 Aug; 14(2):253-9. PubMed ID: 7994241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiautomated autologous bone marrow processing for transplantation.
    Pierelli L; Menichella G; Paoloni A; Serafini R; Vittori M; Foddai ML; Meoni F; Rossi PL; Leone G; Mango G
    Haematologica; 1991 Mar; 76 Suppl 1():10-1. PubMed ID: 1677909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.
    Balzarotti M; Grisanti S; Granzow K; Saladini A; Sala A; Nozza A; Molteni A; Passamonti F; Carlo-Stella C; Santoro A; Siena S
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):66-71. PubMed ID: 10348263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow processing for autotransplantation using an automated cell processor and a semiautomated procedure.
    Pierelli L; Menichella G; Serafini R; de Martini M; Paoloni A; Foddai ML; Scambia G; Benedetti Panici PL; Mancuso S; Leone G
    Bone Marrow Transplant; 1991 May; 7(5):355-61. PubMed ID: 2070144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohamed R
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of Percoll gradient-separated bone marrow.
    Jagannath S; Reading CL; Dicke KA; Tindle S; Devaraj B; Tucker SL; Spitzer G
    Bone Marrow Transplant; 1987 Feb; 1(3):281-8. PubMed ID: 2901872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.